Obesity-associated severe asthma represents a distinct clinical phenotype analysis of the british thoracic society diffi cult asthma registry patient cohort according to bmi

Chest

Volumn 143, Issue 2, 2013, Pages 406-414

  Gibeon, David ^a,c   Batuwita, Kannangara ^b   Osmond, Michelle ^b   Heaney, Liam G ^d   Brightling, Chris E ^e   Niven, Rob ^f   Mansur, Adel ^g   Chaudhuri, Rekha ^h   Bucknall, Christine E ⁱ   Rowe, Anthony ^b   Guo, Yike ^b   Bhavsar, Pankaj K ^c   Chung, Kian Fan ^a,c   Menzies Gow, Andrew ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTON PUMP INHIBITOR; SHORT ACTING DRUG; THEOPHYLLINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHMA; BODY MASS; BONE DENSITY; CARBON MONOXIDE TRANSFER COEFFICIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG THERAPY; ECZEMA; FEMALE; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HUMAN; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REGISTER; RESPIRATORY TRACT PARAMETERS; STEROID BURST THERAPY;

EID: 84874063346     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0872     Document Type: Article

References (34)

1. Dixon AE, Holguin F, Sood A, et al. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc. 2010; 7 (5): 325-335.
2. Shore SA, Johnston RA. Obesity and asthma. Pharmacol Ther. 2006; 110 (1): 83-102.
3. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007: 175 (7): 661-666.
4. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol. 2005; 115 (5): 897-909.
5. Hjellvik V, Tverdal A, Furu K. Body mass index as predictor for asthma: a cohort study of 118,723 males and females. Eur Respir J. 2010; 35 (6): 1235-1242.
6. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax. 2008; 63 (1): 14-20.
7. Akerman MJ, Calacanis CM, Madsen MK. Relationship between asthma severity and obesity. J Asthma. 2004; 41 (5): 421-526.
8. Shore SA. Obesity and asthma: lessons from animal models. J Appl Physiol. 2007; 102 (2): 516-528.
9. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol. 2008; 121 (5): 1087-1093.
10. Haldar P, Pavord ID., Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008; 178 (3): 218-224.
11. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006; 27(3): 495-503.
12. Sutherland ER, Camargo CA Jr, Busse WW, et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy Asthma Proc. 2010; 31 (1): 20-25.
13. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med. 2007; 101 (7): 2240-2247.
14. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med. 2008; 178 (7): 682-687.
15. Heaney LG, Brightling CE, Menzies-Gow A et al. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. Thorax. 2010; 65 (9): 787-794.
16. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med. 2000; 162 (6): 2341-2351.
17. The NHS Information Centre. Lifestyles statistics: statistics on obesity, physical activity and diet: England. NHS Information Centre website. http://www.ic.nhs.uk/statisticsand- data-collections/health-and-lifestyles/ obesity/statistics-onobesity- physical-activity-and-diet-england-2012. 2011. Accessed February 20, 2012.
18. Dolan CM, Fraher KE, Bleecker ER, et al; TENOR Study Group. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004; 92 (1): 32-39.
19. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003; 22 (3): 470-477.
20. Asthma UK. Everyday asthma out of control? UK Asthma website. http://www.asthma.org.uk/document.rm?id 5 93. Accessed February 27, 2012.
21. Healton CG, Vallone D, McCausland KL et al. Smoking, obesity, and their co-occurrence in the United States: cross sectional analysis. BMJ. 2006; 333 (7557): 25-26.
22. Cerveri I, Cazzoletti L, Corsico AG, et al. The impact of cigarette smoking on asthma: a population-based inter na tional cohort study. Int Arch Allergy Immunol. 2012; 158 (2): 175-183.
23. Action On Smoking and Health. Smoking statistics: who smokes and how much. Action On Smoking and Health website. http://ash.org.uk/files/documents/ ASH-106.pdf. Accessed February 27, 2012.
24. Eslick GD. Gastrointestinal symptoms and obesity: a metaanalysis. Obes Rev. 2012; 13 (5): 469-479.
25. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2007; 119 (2): 405-413.
26. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003; 290 (1): 66-72.
27. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999; 106 (6): 642-649.
28. Sutherland TJ, Cowan JO, Young S, et al. The association between obesity and asthma: interactions between systemic and airway infl ammation. Am J Respir Crit Care Med. 2008; 178 (5): 469-475.
29. Moore WC, Meyers DA, Wenzel SE et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010; 181 (4): 315-323.
30. Silverberg JI, Silverberg NB, Lee-Wong M. Association between atopic dermatitis and obesity in adulthood. Br J Dermatol. 2012; 166 (3): 498-504.
31. Greco EA, Fornari R, Rossi F et al. Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. Int J Clin Pract. 2010; 64(6): 817-820.
32. Aaron SD, Vandemheen KL, Boulet LP, et al; Canadian Respiratory Clinical Research Consortium. Overdiagnosis of asthma in obese and nonobese adults. CMAJ. 2008; 179(11): 1121-1131.
33. Collins LC, Hoberty PD, Walker JF, Fletcher EC, Peiris AN. The effect of body fat distribution on pulmonary function tests. Chest. 1995; 107 (5): 1298-1302.
34. Holguin F, Bleecker ER, Busse WW, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011; 127 (6): 1486-1493.